Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Centessa Pharmaceuticals (CNTA) Other Gross PP&E Adjustments (2021 - 2026)

Centessa Pharmaceuticals has reported Other Gross PP&E Adjustments over the past 5 years, most recently at -$9.6 million for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 15.07% to -$9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.6 million through Dec 2025, up 15.07% year-over-year, with the annual reading at -$9.6 million for FY2025, 15.07% up from the prior year.
  • Other Gross PP&E Adjustments was -$9.6 million for Q4 2025 at Centessa Pharmaceuticals, up from -$9.7 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$1.3 million in Q4 2021 and troughed at -$13.9 million in Q1 2023.
  • The 5-year median for Other Gross PP&E Adjustments is -$10.8 million (2025), against an average of -$8.6 million.
  • Year-over-year, Other Gross PP&E Adjustments crashed 877.34% in 2023 and then rose 15.96% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.3 million in 2021, then plummeted by 115.4% to -$2.8 million in 2022, then crashed by 304.54% to -$11.5 million in 2023, then grew by 1.96% to -$11.3 million in 2024, then grew by 15.07% to -$9.6 million in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Other Gross PP&E Adjustments are -$9.6 million (Q4 2025), -$9.7 million (Q3 2025), and -$10.8 million (Q2 2025).